C-V6FYimmunosequencing, TCR/BCR analysis, generative AI
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Monitor therapy-induced T cell dynamics in refractory mismatch repair proficient metastatic colorectal cancer treated with botensilimab and balstilimab.
T cell dynamics monitoring using immune-repertoire analysis during antibody therapy.
2025 publication listed on Omniscope site.
Read the adaptive immune system for applications in oncology, infectious diseases, and autoimmune diseases.
High-throughput TCR and BCR sequencing for immune-repertoire profiling.
Company site presents adaptive immune reading as one of Omniscope's core capabilities.
Write cellular therapeutic designs using generative AI models.
Generative AI models applied to cellular therapeutic design.
Company site presents generative AI cellular-therapy design as one of Omniscope's core capabilities.
Model T cell activity and aging to generate an actionable immune-age measure.
Adaptive immune repertoire analysis using TCR/BCR immune-system data and computational modeling.
2025 publication listed on Omniscope site.
Analyze immune repertoires through a portal-based software environment.
Computational immune-repertoire analysis platform for TCR/BCR sequencing data.
Company site presents the Omniscope Immune Portal as one of Omniscope's core capabilities.
Track T cells over space and time to support personalized TCR-T designs for childhood cancer.
Spatiotemporal T cell tracking using immune-repertoire analysis for personalized TCR-T design.
2025 publication listed on Omniscope site.
Track therapy-induced T cell immunity over space and time in pediatric rhabdoid tumors.
Spatiotemporal tracking of T cell immunity using immune-repertoire analysis.
2025 publication listed on Omniscope site.